4CPS-161 Determination of drug serum levels to optimise treatment of patients with psoriasis

BACKGROUND: Biologic drugs have demonstrated efficacy and safety in the treatment of psoriasis. Frequently, label doses tend to be reduced in clinical practice when a sustained response has been reached. PURPOSE: To assess the proposals of a committee for psoriasis according to drug serum levels and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Hosp Pharm
Egile Nagusiak: Camean-Castillo, M, Rios-Sanchez, E, Gil-Sierra, MD, Briceño-Casado, MDP, Palomo-Palomo, C, Borrero-Rubio, JM, Rey, EJ Alegre-Del, Diaz-Navarro, J, Martinez-Diaz, C, Salmeron-Navas, FJ
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2018
Gaiak:
Section 4: Clinical pharmacy services
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535386/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.252
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak